Table 6 Effect on symptoms following administration of pilocarpine solution to patients with Sjӧgren’s syndrome
Better | Slightly better | Unchanged | Slightly worse | Worse | |
|---|---|---|---|---|---|
Post-administration at 60 min* | 1 (4.2%) | 17 (70.8%) | 5 (20.8%) | 0 (0%) | 1 (4.2%) |
Continuous administration** | 2 (10.5%) | 8 (42.1%) | 9 (47.4%) | 0 (0%) | 0 (0%) |